Status:
WITHDRAWN
Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Conditions:
Olfactory Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of onset immediately after an upper respiratory viral illness, assigned to three distinct study arms. Nasal ir...
Eligibility Criteria
Inclusion
- Adults 18 years of age or older
- Hyposmia/anosmia of onset immediately after an upper respiratory viral illness confirmed on Snap n' Sniff threshold testing,
- Capable, in the opinion of the primary investigator, of providing informed consent to participate in the study. Participants are required to sign an informed consent form indicating they understand the purpose and nature of the study, and that they are willing to participate.
Exclusion
- active cigarette smoker
- chronic rhinosinusitis
- head trauma with loss of consciousness
- inability to read/understand English
- previous hyposmia/anosmia complaint
- pregnancy
- previous sinus
- skull base or brain surgery
- current participation in another clinical trial at the time of initial visit
Key Trial Info
Start Date :
January 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04374474
Start Date
January 10 2021
End Date
March 10 2022
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Health Care
London, Ontario, Canada, N5A 4V2